Biogen
BIIB
#674
Rank
$27.69 B
Marketcap
$190.52
Share price
-0.85%
Change (1 day)
-35.16%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Net assets

Net assets on the balance sheet as of December 2023 : $14.79 B

According to Biogen's latest financial reports the company has $14.79 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Biogen - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2023-12-31$14.79 B10.54%
2022-12-31$13.38 B22.16%
2021-12-31$10.95 B2.56%
2020-12-31$10.68 B-19.89%
2019-12-31$13.33 B2.36%
2018-12-31$13.03 B3.44%
2017-12-31$12.59 B3.87%
2016-12-31$12.12 B29.37%
2015-12-31$9.37 B-13.31%
2014-12-31$10.81 B25.44%
2013-12-31$8.62 B23.8%
2012-12-31$6.96 B8.35%
2011-12-31$6.42 B17.94%
2010-12-31$5.44 B-12.97%
2009-12-31$6.26 B7.34%
2008-12-31$5.83 B5.41%
2007-12-31$5.53 B-22.59%
2006-12-31$7.14 B3.53%
2005-12-31$6.90 B1.16%
2004-12-31$6.82 B-3.22%
2003-12-31$7.05 B535.61%
2002-12-31$1.10 B-17.73%
2001-12-31$1.34 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$68.77 B 364.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$89.28 B 503.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.39 B-29.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.23 B-57.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$82.20 B 455.45%๐Ÿ‡ซ๐Ÿ‡ท France
$22.74 B 53.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.74 B-61.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$58.95 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.80 B-74.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$8.74 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA